Many of the world's leading causes of irreversible blindness, including glaucoma and age-related macular degeneration, share ...

A new study links spring daylight saving time changes to an up to 30% increased risk of retinal vascular disease.

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Back ...

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease type 1, having met the primary efficacy endpoint, reduction in lesion growth Presentation to ...

Learn about teprotumumab for moderate to severe thyroid eye disease, its benefits, risks, as well as evolving treatment ...

Sunir Garg, MD, expresses excitement about attending AAO 2025 and focuses on several topics to be discussed. These include the benefits and potential vision risks of GLP-1 inhibitors in patients with ...

Here’s what to know about the irreversible eye disease at the center of the new National Geographic documentary Blink. Retinitis pigmentosa is a rare visual disorder that affects a layer of tissue in ...

Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness after cataracts in ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

In a genetic association study, investigators integrated data from genome-wide association studies of various disorders with retinal transcriptomic data. Findings revealed that the polygenic risk of ...

K8 slowed disease progression and trended towards improving visual acuity, which Inflammasome says warrants the drug’s further evaluation.

Discover the benefits of multidisciplinary clinics for thyroid eye disease, including coordinated care, treatment options, ...